Correlation Between Kuang Chi and Cansino Biologics

Can any of the company-specific risk be diversified away by investing in both Kuang Chi and Cansino Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kuang Chi and Cansino Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Kuang Chi Technologies and Cansino Biologics, you can compare the effects of market volatilities on Kuang Chi and Cansino Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kuang Chi with a short position of Cansino Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kuang Chi and Cansino Biologics.

Diversification Opportunities for Kuang Chi and Cansino Biologics

0.85

Correlation Coefficient

Kuang Chi  Cansino Biologics

Very poor diversification

The 3 months correlation between Kuang and Cansino is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Kuang Chi Technologies and Cansino Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cansino Biologics and Kuang Chi is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kuang Chi Technologies are associated (or correlated) with Cansino Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cansino Biologics has no effect on the direction of Kuang Chi i.e., Kuang Chi and Cansino Biologics go up and down completely randomly.

Pair Corralation between Kuang Chi and Cansino Biologics

Assuming the 90 days trading horizon Kuang Chi Technologies is expected to generate 1.16 times more return on investment than Cansino Biologics. However, Kuang Chi is 1.16 times more volatile than Cansino Biologics. It trades about 0.2 of its potential returns per unit of risk. Cansino Biologics is currently generating about -0.08 per unit of risk. If you would invest  4,005  in Kuang Chi Technologies on September 25, 2024 and sell it today you would earn a total of  407.00  from holding Kuang Chi Technologies or generate 10.16% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	95.45%
Values	Daily Returns

Kuang Chi Technologies  vs.  Cansino Biologics

Kuang Chi Technologies

Risk-Adjusted Performance

22 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Kuang Chi Technologies are ranked lower than 22 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Kuang Chi sustained solid returns over the last few months and may actually be approaching a breakup point.

Cansino Biologics

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Cansino Biologics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Cansino Biologics sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Kuang Chi and Cansino Biologics

The main advantage of trading using opposite Kuang Chi and Cansino Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kuang Chi position performs unexpectedly, Cansino Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cansino Biologics will offset losses from the drop in Cansino Biologics' long position.

The idea behind Kuang Chi Technologies and Cansino Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.